Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1038114 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Fluoride SCHEMBL3259338 | 0.98 | LMNA (0.41) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Fluoride SCHEMBL11097713 | 0.94 | LMNA (0.43) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Avridine SCHEMBL6741009 | 0.91 | LMNA (0.35) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Fluoride SCHEMBL11099490 | 0.90 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL268149 | 0.88 | DNM1 (0.39) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL10994980 | 0.81 | LMNA (0.44) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL1970702 | 0.81 | LMNA (0.44) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL31099214 | 0.80 | LMNA (0.39) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL28833442 | 0.79 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 689 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220211842-A1 | Methods and Devices for the Treatment of Food Allergies | TEXAS TECH UNIVERSITY SYSTEM | 2022-07-07 | — | — | US | claimed |
| US-11369671-B2 | Vaccine to prevent mycoplasmal infections in waterfowl | GALENBIO, INC. (US) | 2022-06-28 | — | — | US | claimed |
| EP-3688146-A1 | PORCINE ASTROVIRUSES AND THE USES THEREOF | Ceva Sante Animale (FR) | 2020-08-05 | — | — | EP | claimed |
| EP-3630175-A1 | METHODS AND DEVICES FOR THE TREATMENT OF FOOD ALLERGIES | Texas Tech University System (US) | 2020-04-08 | — | — | EP | claimed |
| WO-2019057953-A1 | PORCINE ASTROVIRUSES AND THE USES THEREOF | CEVA SANTE ANIMALE (FR) | 2019-03-28 | — | — | WO | claimed |
| EP-3460053-A1 | PORCINE ASTROVIRUSES AND THE USES THEREOF | Ceva Sante Animale (FR) | 2019-03-27 | — | — | EP | claimed |
| WO-2018222874-A1 | METHODS AND DEVICES FOR THE TREATMENT OF FOOD ALLERGIES | TEXAS TECH UNIVERSITY SYSTEM (US) | 2018-12-06 | — | — | WO | claimed |
| EP-3310384-A1 | VACCINE COMPOSITION | CureVac AG (DE) | 2018-04-25 | — | — | EP | claimed |
| WO-2016203025-A1 | VACCINE COMPOSITION | CUREVAC AG (DE) | 2016-12-22 | — | — | WO | claimed |
| US-20160082094-A1 | VACCINE TO PREVENT MYCOPLASMAL INFECTIONS IN WATERFOWL | GALENBIO, INC. | 2016-03-24 | — | — | US | claimed |
| US-20050238662-A1 | Circovirus sequences associated with piglet weight loss disease (PWD) | AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENTS | 2005-10-27 | — | — | US | claimed |
| US-20050118200-A1 | Vaccines for Mycoplasma bovis and methods of use | LEONARD JOAN D (US) | 2005-06-02 | — | — | US | claimed |
| US-20040258715-A1 | Porcine circoviruses, vaccines and diagnostic reagents | MERIAL SAS (FR) | 2004-12-23 | — | — | US | claimed |
| EP-1427349-A2 | INTERLEUKIN-12 AS A VETERINARY VACCINE ADJUVANT | Wyeth (US) | 2004-06-16 | — | — | EP | claimed |
| US-20040009897-A1 | Stabilized synthetic immunogen delivery system | VAXXINITY, INC. | 2004-01-15 | — | — | US | claimed |
| US-6660272-B2 | For protection against Porcine Multisystemic Wasting Syndrome also called Post- weaning Multisystemic Wasting Syndrome | MERIAL (FR) | 2003-12-09 | — | — | US | claimed |
| US-20030129161-A1 | Interleukin-12 as a veterinary vaccine adjuvant | WYETH | 2003-07-10 | — | — | US | claimed |
| WO-2003024354-A2 | INTERLEUKIN-12 AS A VETERINARY VACCINE ADJUVANT | WYETH (US) | 2003-03-27 | — | — | WO | claimed |
| WO-2000051647-A2 | ANIMAL MODEL OF ALLERGIES | MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY (US) | 2000-09-08 | — | — | WO | claimed |
| US-5080896-A | Adjuvant Coupled to Antigen | AKZO N. V. (NL) | 1992-01-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160082094-A1 | VACCINE TO PREVENT MYCOPLASMAL INFECTIONS IN WATERFOWL | MYH10, RAD50, S100A10 | LMNA 1153/4885ALDH1A1 4300/4885HSD17B10 760/4885 |
| US-20040009897-A1 | Stabilized synthetic immunogen delivery system | TLR9, MYD88, IFNG | LMNA 3884/4885ALDH1A1 4884/4885HSD17B10 4816/4885 |
| US-11369671-B2 | Vaccine to prevent mycoplasmal infections in waterfowl | MYH10, RAD50, S100A10 | LMNA 1153/4885ALDH1A1 4300/4885HSD17B10 760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.